ATE13667T1 - 8-aza-16,16-difluor-prostanoide. - Google Patents

8-aza-16,16-difluor-prostanoide.

Info

Publication number
ATE13667T1
ATE13667T1 AT81303641T AT81303641T ATE13667T1 AT E13667 T1 ATE13667 T1 AT E13667T1 AT 81303641 T AT81303641 T AT 81303641T AT 81303641 T AT81303641 T AT 81303641T AT E13667 T1 ATE13667 T1 AT E13667T1
Authority
AT
Austria
Prior art keywords
aza
difluoroprostanoids
stereo
active
prostanoids
Prior art date
Application number
AT81303641T
Other languages
English (en)
Inventor
Richard Merrill Scribner
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of ATE13667T1 publication Critical patent/ATE13667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT81303641T 1980-08-11 1981-08-10 8-aza-16,16-difluor-prostanoide. ATE13667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/176,784 US4320136A (en) 1980-08-11 1980-08-11 8-Aza-16,16-difluoroprostanoids
EP81303641A EP0046082B1 (de) 1980-08-11 1981-08-10 8-Aza-16,16-difluor-prostanoide

Publications (1)

Publication Number Publication Date
ATE13667T1 true ATE13667T1 (de) 1985-06-15

Family

ID=22645804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81303641T ATE13667T1 (de) 1980-08-11 1981-08-10 8-aza-16,16-difluor-prostanoide.

Country Status (7)

Country Link
US (1) US4320136A (de)
EP (1) EP0046082B1 (de)
JP (1) JPS5754166A (de)
AT (1) ATE13667T1 (de)
CA (1) CA1161447A (de)
DE (1) DE3170838D1 (de)
DK (1) DK352281A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
JP3984164B2 (ja) * 2000-11-27 2007-10-03 ファイザー・プロダクツ・インク 骨粗鬆症治療用ｅｐ４受容体選択的アゴニスト
CA2451393C (en) * 2001-07-16 2011-01-04 F. Hoffmann-La Roche Ag 2 pyrrolidone derivatives as prostanoid agonists
ES2254726T3 (es) 2001-07-16 2006-06-16 F. Hoffmann-La Roche Ag Analogos de prostaglandina como agonistas receptores de ep4.
JP4273407B2 (ja) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
US20040254230A1 (en) * 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
KR100752891B1 (ko) * 2003-01-10 2007-08-28 에프. 호프만-라 로슈 아게 프로스타글란딘 작용제로서 2-피페리돈 유도체
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists
CA2738045C (en) * 2010-05-28 2019-02-19 Simon Fraser University Conjugate compounds, methods of making same, and uses thereof
SI2875022T1 (sl) 2012-07-19 2017-04-26 Cayman Chemical Company, Incorporated Spojine difluorolaktama kot selektivni antagonisti EP4 za uporabo pri zdravljenju z EP4-povzročenih bolezni in stanj
EP2970234B1 (de) 2013-03-15 2018-07-18 Cayman Chemical Company, Inc. Verfahren zur herstellung eines difluorolactam-analogons
EP3235817B1 (de) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Lactamverbindungen als ep4-rezeptorselektive agonisten zur verwendung bei der behandlung von ep4-vermittelten erkrankungen und zuständen
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CN105392505A (zh) 2013-07-19 2016-03-09 开曼化学股份有限公司 用于促进骨生长的方法、系统和组合物
US9650414B1 (en) 2014-05-30 2017-05-16 Simon Fraser University Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof
US10400000B2 (en) 2015-06-12 2019-09-03 Simon Fraser University Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873566A (en) * 1973-02-28 1975-03-25 Du Pont 3-Pyrazolidinones and pyrazolidines
US3974191A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin F1 analogs
US3974189A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin E2 analogs
US3974190A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin A1 analogs
US3974193A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin B2 analogs
US3969378A (en) * 1973-07-20 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin A2 analogs
US3969376A (en) * 1973-07-20 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3974192A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin B1 analogs
US4187381A (en) * 1973-08-06 1980-02-05 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4017534A (en) * 1974-06-03 1977-04-12 American Cyanamid Company 16-Fluoro-11-deoxy-13-dihydro-prostaglandin
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
US3969381A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969379A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US3969377A (en) * 1975-02-21 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin E1 analogs
US3969380A (en) * 1975-02-21 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin F2 analogs
US4113873A (en) * 1975-04-26 1978-09-12 Tanabe Seiyaku Co. Ltd. 8-azaprostanoic acid derivatives
US4003911A (en) * 1975-09-26 1977-01-18 E. I. Du Pont De Nemours And Company Selected 3-pyrrolidinones and 2,4-pyrrolidindiones
US4032533A (en) * 1976-02-19 1977-06-28 E. I. Du Pont De Nemours And Company 3,4-disubstituted-1,3,4-thiadiazoline-2,5-diones
IL49325A (en) * 1976-03-31 1979-11-30 Labaz 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
DE2619638A1 (de) 1976-05-04 1977-11-17 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4177346A (en) * 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
US4211876A (en) * 1979-06-13 1980-07-08 E. I. Du Pont De Nemours And Company 3-Pyrazolidinone carboxamides

Also Published As

Publication number Publication date
US4320136A (en) 1982-03-16
EP0046082A2 (de) 1982-02-17
EP0046082B1 (de) 1985-06-05
JPS5754166A (en) 1982-03-31
CA1161447A (en) 1984-01-31
EP0046082A3 (en) 1982-03-03
DE3170838D1 (en) 1985-07-11
DK352281A (da) 1982-02-12

Similar Documents

Publication Publication Date Title
ATE13667T1 (de) 8-aza-16,16-difluor-prostanoide.
FI841480L (fi) Anvaendning av klordioxidgas som ett kemiskt steriliseringsmedel.
LU88359I2 (fr) Claritine
FI844752A7 (fi) Substituoidut trans -1,2-diaminosykloheksyyli-amidiyhdisteet.
ES8704931A1 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
DE3382389D1 (de) Plasminogenaktivator.
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
NL189272C (nl) Bipolaire transistor.
DE3381898D1 (de) Prostaglandin enthaltende zusammensetzungen.
FI834473A7 (fi) Amidfoereningar.
FI832884A0 (fi) Desoxiuridinderivat, deras framstaellningsfoerfaranden och anvaendning som farmaceutiska medel
NO160325C (no) Demonterbar stolfot.
FI812539L (fi) Substituerade enantolaktamderivat som antihypertensiva medel
NO152667C (no) Lyddempningsanordning for blandeventil.
BG40952A3 (en) Herbicide means
FI834044A7 (fi) Pesuaine-pehmenninseos.
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
BG36931A3 (en) Method for preparing substituted benzamide
FI834588L (fi) Vattenhaltigt haerdningsmedel foer laettmetallegeringar pao aluminiumbas.
TR22867A (tr) Birden fazla aktif bilesen ihtiva eden insektisid terkibi
BG42351A3 (bg) Средство за регулиране растежа на растения
SU1345402A1 (ru) Дезинфицирующее средство
SU1066155A1 (ru) п-Толилсульфонилгидразиды диарилгликолевых кислот, проявляющие ростстимулирующую активность
SE8207186D0 (sv) Terapeutiskt aktiva, membranstabiliserande medel
SU1095573A1 (ru) Стабилизатор хлоруглеводородов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee